ArticleInflammatory intestinal diseases

Endoscopic Outcomes of Risankizumab in Crohn's Disease: A Real-World Analysis of Terminal Ileal Lesions.

Kazuhiko Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.